The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma

BACKGROUND: To elucidate the incidence and mechanisms of sunitinib-induced thyroid atrophy, we investigated serial volumetric and functional changes, and evaluated histological changes of the thyroid gland in metastatic renal cell carcinoma patients who received sunitinib. METHODS: Thyroid volume (b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shinohara, N, Takahashi, M, Kamishima, T, Ikushima, H, Otsuka, N, Ishizu, A, Shimizu, C, Kanayama, H, Nonomura, K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031892/
https://www.ncbi.nlm.nih.gov/pubmed/21157447
http://dx.doi.org/10.1038/sj.bjc.6606029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031892/
https://www.ncbi.nlm.nih.gov/pubmed/21157447
http://dx.doi.org/10.1038/sj.bjc.6606029

Ejemplares similares